Tech Company Financing Transactions
Qureight Funding Round
Qureight closed a $8.5 million Series A funding round on 4/16/2024. Investors included Hargreave Hale, Ascension Ventures and Cambridge Angels.
Transaction Overview
Company Name
Announced On
4/16/2024
Transaction Type
Venture Equity
Amount
$8,500,000
Round
Series A
Investors
Hargreave Hale (Lead Investor) (Lucy Bloomfield)
Proceeds Purpose
The funds will accelerate Qureight's AI-driven product portfolio and expand into new diseases, including lung cancer.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Nine Hills Road
Cambridge, CB2 1GE
UK
Cambridge, CB2 1GE
UK
Phone
Undisclosed
Website
Email Address
Overview
Our mission is to accelerate clinical trial development at key decision points through data curation and AI-powered decision making. We work with pharmaceutical companies, contract research organisations and hospitals to curate data and help the best drugs get approved so they can be given to patients with lung and heart diseases who need them.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Muhunthan Thillai
Chief Scientific Officer
Alessandro Ruggiero
Chief Technical Officer
Darren Gallagher
Browse more venture capital transactions:
Prev: 4/16/2024: Loft Labs venture capital transaction
Next: 4/16/2024: Kontakt.io venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to record every notable VC transaction. VC transactions on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs